These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33723056)

  • 1. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.
    Sun T; Yu Y; Wu X; Acevedo A; Luo JD; Wang J; Schneider WM; Hurwitz B; Rosenberg BR; Chung H; Rice CM
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
    Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
    PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
    Nakahama T; Kawahara Y
    Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ADAR1 p150 and p110 Associated Edit Sites.
    Sun T; Rosenberg BR; Chung H; Rice CM
    Methods Mol Biol; 2023; 2651():285-294. PubMed ID: 36892775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adenosine deaminase acting on RNA 1 p150 isoform is involved in the pathogenesis of dyschromatosis symmetrica hereditaria.
    Zhang JY; Chen XD; Zhang Z; Wang HL; Guo L; Liu Y; Zhao XZ; Cao W; Xing QH; Shao FM
    Br J Dermatol; 2013 Sep; 169(3):637-44. PubMed ID: 23621630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of RNA editing enzyme ADAR1 in human disease.
    Song B; Shiromoto Y; Minakuchi M; Nishikura K
    Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyschromatosis Symmetrica Hereditaria and Aicardi-Goutières Syndrome 6 Are Phenotypic Variants Caused by ADAR1 Mutations.
    Kono M; Matsumoto F; Suzuki Y; Suganuma M; Saitsu H; Ito Y; Fujiwara S; Moriwaki S; Matsumoto K; Matsumoto N; Tomita Y; Sugiura K; Akiyama M
    J Invest Dermatol; 2016 Apr; 136(4):875-878. PubMed ID: 26802932
    [No Abstract]   [Full Text] [Related]  

  • 8. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
    Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
    J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-occurrence of Aicardi-Goutières syndrome type 6 and dyschromatosis symmetrica hereditaria due to compound heterozygous pathogenic variants in ADAR1: a case series from India.
    Sathishkumar D; Muthusamy K; Gupta A; Malhotra M; Thomas M; Koshy B; Jasper A; Danda S; George R
    Clin Exp Dermatol; 2021 Jun; 46(4):704-709. PubMed ID: 33289110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA editing of AZIN1 coding sites is catalyzed by ADAR1 p150 after splicing.
    Xing Y; Nakahama T; Wu Y; Inoue M; Kim JI; Todo H; Shibuya T; Kato Y; Kawahara Y
    J Biol Chem; 2023 Jul; 299(7):104840. PubMed ID: 37209819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
    Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
    Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
    Nakahama T; Kawahara Y
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
    Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
    J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of ADAR1 isoforms in murine acute T-ALL leukemia model].
    Ma CH; Tian C; Chong JH; Shi YX; Wang JH; Lin YM; Xu J; Zheng GG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):566-9. PubMed ID: 21729523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).
    George CX; John L; Samuel CE
    J Interferon Cytokine Res; 2014 Jun; 34(6):437-46. PubMed ID: 24905200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms.
    Kleinova R; Rajendra V; Leuchtenberger AF; Lo Giudice C; Vesely C; Kapoor U; Tanzer A; Derdak S; Picardi E; Jantsch MF
    Nucleic Acids Res; 2023 May; 51(9):4191-4207. PubMed ID: 37026479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.
    George CX; Ramaswami G; Li JB; Samuel CE
    J Biol Chem; 2016 Mar; 291(12):6158-68. PubMed ID: 26817845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.
    Pestal K; Funk CC; Snyder JM; Price ND; Treuting PM; Stetson DB
    Immunity; 2015 Nov; 43(5):933-44. PubMed ID: 26588779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: An update.
    Kono M; Akiyama M
    J Dermatol Sci; 2019 Feb; 93(2):75-81. PubMed ID: 30692041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.